Pamela Bailey to Exit as Chair of Integer Holdings; Donald Spence Set to Succeed
Pamela G. Bailey, current independent Chair of Integer Holdings (NYSE: ITGR), will not seek re-election at the 2026 Annual Meeting. Donald J. Spence, a current board member since 2016, is slated to succeed her as independent Chair. Spence has extensive experience in the medical device industry, having previously served as CEO of Ebb Therapeutics and Lake Region Medical.
Integer Announces Board Leadership Transition
Integer Holdings Corporation (NYSE: ITGR) announced a board leadership transition, with Pamela G. Bailey not seeking re-election as independent Chair. Donald J. Spence, a current director, will assume the role of independent Chair of the Board after the 2026 Annual Meeting of Stockholders on May 20, 2026. This transition follows Ms. Bailey's successful tenure and is expected to maintain close collaboration between the board and the executive team.
Integer lines up Donald Spence as next independent board chair
Integer Holdings Corporation announced that its independent Board Chair, Pamela G. Bailey, will not seek re-election at the 2026 Annual Meeting of Stockholders on May 20, 2026. The Board intends to appoint current director Donald J. Spence as the next independent Chair. Spence, who has served on the Board since 2016, currently chairs the Compensation & Organization Committee and has significant executive experience in the medical device industry.
Integer Holdings (NYSE: ITGR) details 2026 proxy, pay plan and new share reserve
Integer Holdings is seeking stockholder approval for four key items at its 2026 Annual Meeting, including the election of 11 directors, auditor ratification, an advisory vote on executive pay, and the adoption of a new 2026 Omnibus Incentive Plan. The company highlights strong 2025 financial performance with increased sales and adjusted operating income, alongside a compensation philosophy that links executive pay to performance. The proposed incentive plan aims to authorize new shares while maintaining governance best practices and a modest dilution rate.
Medical device manufacturing giant Integer Holdings Corporation recently announced that its board of directors has approved a resolution to officially appoint Donald J. Spence as Independent Chairman following the 2026 Annual Shareholders' Meeting.
Integer Holdings Corporation's board of directors has resolved to appoint Donald J. Spence as Independent Chairman after the 2026 Annual Shareholders' Meeting. This move is intended to reinforce the company's governance structure and uphold the independence of its Board of Directors. The announcement highlights the medical device manufacturer's commitment to strategic personnel arrangements for long-term stability.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integer Holdings Corporation (ITGR) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by Integer Holdings Corporation (ITGR). The firm encourages investors who purchased Integer securities before July 25, 2024, and still hold them, to come forward and assist with the investigation. The firm operates on a contingency fee basis, seeking reimbursement only if successful in recovering funds for investors.
Integer (NYSE: ITGR) EVP exercises 3,837 RSUs; 1,842 shares withheld
John A. Harris, EVP of Integer Holdings Corp (NYSE: ITGR), exercised 3,837 restricted stock units (RSUs) which converted into common shares. Following the conversion, 1,842 shares were withheld to cover tax liabilities at $88.00 per share. After these transactions, Harris directly holds 8,657 shares of Integer Holdings common stock.
Integer Announces Conference Call to Discuss First Quarter 2026 Results
Integer Holdings Corporation (NYSE: ITGR), a medical device contract development and manufacturing organization, announced that it will host a webcast conference call on Thursday, April 30, 2026, at 8 a.m. CT (9 a.m. ET) to discuss its first-quarter 2026 financial results and business highlights. The company will issue a news release with these financial results prior to the call on the same date. An audio replay will be available for seven days, and the webcast will also be archived on the Investor Relations section of Integer's website.
Integer Announces Conference Call to Discuss First Quarter 2026 Results
Integer Holdings Corporation (NYSE: ITGR) has announced that it will host a webcast conference call on Thursday, April 30, 2026, at 8 a.m. CT (9 a.m. ET) to discuss its financial results and business highlights for the first quarter ended April 3, 2026. The company will issue a news release with its financial results prior to the call. Details for accessing the conference call and a subsequent audio replay have been provided.
Integer to release Q1 results April 30 before 8 a.m. CT webcast
Integer Holdings Corporation will webcast its first-quarter 2026 financial results conference call on Thursday, April 30, 2026, at 8 a.m. CT (9 a.m. ET). The company plans to release its financial results via news release earlier that day. Investors can find dial-in information and a webcast registration link on Integer's Investor Relations website, with an audio replay available for seven days.
ITGR SEC Filings - Integer Hldgs Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Integer Holdings Corporation (ITGR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider trading forms. It features AI-powered summaries, impact scoring, and sentiment analysis for each filing, offering detailed insights into the company's financial performance, governance, and capital structure. Recent filings include insider purchases, a common stock buyback authorization, CEO changes, and Q3 2025 earnings reports.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integer Holdings Corporation (ITGR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Integer Holdings Corporation (ITGR) and its officers and directors. The firm is encouraging investors who purchased Integer securities before July 25, 2024, and still hold them, to connect and assist with the investigation. This class action aims to recover investor capital and ensure corporate accountability.
Integer Holdings Corp. Experiences Valuation Adjustment Amid Market Dynamics and Peer Comparison
Integer Holdings Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has seen a recent valuation adjustment. Despite a 27.38% decline over the past year, contrasting with the S&P 500's gain, the company maintains a relatively stable market position compared to its peers like Sanmina Corp., Glaukos Corp., and iRhythm Technologies. Key financial metrics such as a P/E ratio of 28 and an EV to EBITDA of 11.69 highlight its distinct standing in the industry.
ITGR6352821 Bond Price and Chart — FINRA:ITGR6352821
This article provides details on the Integer Holdings Corporation 1.875% 15-MAR-2030 bond (FINRA:ITGR6352821), including its current price chart, key terms such as outstanding amount, coupon rate, and maturity date, and information about the issuer. It highlights the bond's financial specifications and the company's profile as a medical device manufacturer. The page also mentions the availability of advanced bond data upon signing up.
Assessing Integer Holdings (ITGR) Valuation After Recent Share Price Pullback
Integer Holdings (ITGR) has seen a recent share price pullback but is still positive over the past week and three months. Simply Wall St's analysis suggests the stock is undervalued with a fair value of $93.25 against its current trading price of $85.33, driven by a strong pipeline in fast-growing medical technology sectors. The article emphasizes reviewing risks like product line performance and OEM customer shifts, and encourages investors to explore further resources on undervalued or resilient stocks.
Vanguard disaggregates holdings; Integer Holdings (NASDAQ: ITGR) shows 0 shares
The Vanguard Group has filed an amended Schedule 13G for Integer Holdings (NASDAQ: ITGR), reporting 0 shares beneficially owned and 0% of the common stock. This change is due to an internal realignment effective January 12, 2026, which requires certain Vanguard subsidiaries and divisions to report their beneficial ownership separately. The amendment is administrative and does not indicate any sale of ITGR shares by Vanguard.
Integer Holdings (ITGR) director James Francis Flanagan files initial insider Form 3
Integer Holdings Corp director James Francis Flanagan has filed an initial insider ownership report (Form 3). This filing establishes his status as a company director but does not indicate any stock transactions such as purchases, sales, or option exercises at this time. The Form 3 serves as a baseline for future insider transaction reporting, enhancing transparency for investors.
Integer Holdings (ITGR) director discloses 960-share common stock stake
Integer Holdings Corp director Aaron Kapito has filed an initial ownership statement, reporting a direct stake of 960.6770 shares of Common Stock in the company. The filing, a Form 3, did not disclose any buy or sell transactions. This new disclosure follows Integer's recent announcement on March 12, 2026, of Mr. Kapito's appointment to its Board of Directors.
Director at Integer Holdings (NYSE: ITGR) receives 410-share RSU equity grant
Integer Holdings Corp director James Francis Flanagan was granted 410 restricted stock units (RSUs) on March 12, 2026. These RSUs will convert into common stock on a one-for-one basis and are scheduled to vest on May 19, 2026. This transaction is a compensation grant, not an open-market purchase, and after the grant, Flanagan directly holds 410 shares from this award.
Integer (NYSE: ITGR) director awarded 410 restricted stock units
Integer Holdings Corp (NYSE: ITGR) director Aaron Kapito was granted 410 restricted stock units (RSUs) on March 12, 2026. These RSUs will vest on May 19, 2026, converting into common stock on a one-for-one basis. Following this award, Kapito directly holds 1,370.677 shares of Integer Holdings.
Notice to Long-Term Shareholders of ASP Isotopes Inc.
Grabar Law Office is investigating claims on behalf of long-term shareholders of ASP Isotopes Inc., Integer Holdings Corp., Molina Healthcare, Inc., and Soleno Therapeutics, Inc. The investigations concern potential breaches of fiduciary duties and securities law violations by these companies' officers and directors. Shareholders who purchased shares before specific dates and still hold them may be eligible to seek corporate reforms, return of funds, and a court-approved incentive award.
Integer Holdings Corporation $ITGR Shares Bought by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL significantly increased its stake in Integer Holdings Corporation (NYSE:ITGR), purchasing over 29 million additional shares. This comes after Integer beat its latest quarterly earnings and revenue expectations and issued strong FY2026 guidance. Institutional ownership remains very high, although analyst ratings are mixed with a consensus "Hold" rating.
Integer Holdings Corp Aktie under Investigation Pressure: NYSE Trading at $84.36 Amid Legal Scrutiny
Integer Holdings Corp is facing legal scrutiny as law firms Portnoy Law and Bronstein, Gewirtz & Grossman launched investigations into potential securities issues, announced on March 19, 2026. Despite reporting solid Q4 2025 earnings and positive Q3 2025 results, the medical device maker's stock on the NYSE traded at $84.36, down 0.40%, due to these probes. The investigations highlight risks for investors in the medtech sector, contrasting with the company's strong financial performance and its role as a key supplier in medical device manufacturing.
KeyBanc reiterates Integer Holdings stock rating on recovery plan
KeyBanc has reiterated an Overweight rating and a $99.00 price target for Integer Holdings (NYSE:ITGR), noting that the company's recovery plan is progressing as scheduled for 2026 and 2027. The first half of 2026 is expected to see a slight decline due to product headwinds, with a return to market growth in the second half and sustained growth in 2027 driven by new product launches. The analyst's confidence is further supported by the company's strong Q4 2025 financial results, which exceeded analyst expectations.
Important Notice to Long-Term Shareholders of ASP Isotopes
Grabar Law Office is investigating claims on behalf of long-term shareholders of ASP Isotopes Inc. (NASDAQ: ASPI), Integer Holdings Corp. (NYSE: ITGR), Soleno Therapeutics, Inc. (NASDAQ: SLNO), and Unicycive Therapeutics, Inc. (NASDAQ: UNCY). These investigations concern alleged violations of federal securities laws and breaches of fiduciary duties by the companies' officers and directors, stemming from allegedly false or misleading statements regarding their business prospects and products. Shareholders who held shares before specified dates are encouraged to contact the law office to potentially seek corporate reforms and the return of funds.
Integer Holdings VP Thomas sells $70k in stock By Investing.com
Integer Holdings VP, Corporate Controller, Tommy P. Thomas, sold 825 shares of common stock for a total of $70,125 on March 13, 2026. Following this transaction, Thomas retains 4,381 shares. Integer Holdings (NYSE:ITGR) is considered undervalued with a "GOOD" financial health score, and net income is expected to grow this year.
Integer Holdings VP Thomas sells $70k in stock
Integer Holdings Corp VP, Corporate Controller, Tommy P. Thomas, sold 825 shares of common stock for a total of $70,125. Following the transaction, Thomas directly owns 4,381 shares. The company shows growth potential with a "GOOD" financial health score and recent strong fourth-quarter results for 2025.
Integer Holdings (NYSE: ITGR) VP sells 825 common shares at $85
Integer Holdings Corp's VP, Corporate Controller, Thomas Tommy P, sold 825 shares of common stock at $85.00 per share on March 13, 2026. This open-market transaction was reported on a Form 4 SEC filing. Following the sale, Mr. P directly owns 4,381 common shares of the company.
Artisan Small Cap Fund Sold Integer Holdings (ITGR) as Thesis Did Not Materialize
Artisan Small Cap Fund sold its position in Integer Holdings Corporation (ITGR) during Q4 2025 because its investment thesis, based on strong earnings growth, increased outsourcing, and margin expansion, did not materialize. The company experienced slower revenue growth, stagnant margins, and a leadership transition, leading to increased concerns for the fund. Despite strong overall returns for Artisan Small Cap Fund in Q4 2025, they exited ITGR due to these unmet expectations.
Bamco Inc. NY Has $79.16 Million Holdings in Integer Holdings Corporation $ITGR
Bamco Inc. NY significantly increased its stake in Integer Holdings Corporation (NYSE:ITGR) by 81.4%, now holding 766,055 shares valued at $79.16 million. Integer recently surpassed quarterly earnings estimates and provided optimistic FY2026 guidance, which is above analyst consensus. While positive developments like a board reshuffle and upgraded long-term estimates serve as catalysts, near-term quarterly estimate cuts could temporarily impact sentiment.
What Integer Holdings (ITGR)'s Activist Board Deal and Governance Reset Means For Shareholders
Integer Holdings Corporation has reached a cooperation agreement with activist investor Irenic Capital Management, leading to the appointment of two new directors, James F. Flanagan and Aaron Kapito, to its board. This governance change introduces financial and activist-investor experience at a time when Integer's business practices are facing scrutiny. The article discusses how this reset, alongside recent modest growth guidance, will impact the company's investment narrative and shareholder expectations for execution on margins and contract stability.
Integer Holdings Reaches Cooperation Agreement With Activist Investor
Integer Holdings has announced a cooperation agreement with Irenic Capital Management, leading to the appointment of two independent directors, James Flanagan and Aaron Kapito, to its Board. This agreement, effective March 12, 2026, aims to strengthen governance and align capital allocation with shareholder priorities, with Irenic withdrawing its competing director slate. The company, a medical device CDMO, is targeting improved organic sales growth in 2026 and beyond.
Integer Appoints James Flanagan and Aaron Kapito to Board of Directors
Integer Holdings Corporation has appointed James Flanagan and Aaron Kapito to its Board of Directors. Flanagan joins as an independent director, while Kapito's appointment is in connection with a cooperation agreement with Irenic Capital Management. These appointments are expected to enhance Integer's focus on growth and value creation, leveraging the new directors' expertise in finance, governance, risk management, and strategic planning.
Integer Holdings Corp Stock Rebounds on Activist Board Deal as Medical Device Maker Eyes 2027 Growth
Integer Holdings Corp (ISIN: US45826J1051) has settled its proxy battle with activist investor Irenic Capital, appointing two new independent directors to its board. While the market reaction was initially skeptical, some investors view the stock's current price as attractive given its asset base and growth prospects, especially with expectations for above-market growth by 2027. However, the company faces scrutiny regarding its premium valuation, earnings quality concerns due to a gap between adjusted and GAAP earnings, and the critical test of its upcoming Q1 2026 earnings report to justify its strategic direction.
Magnetar Financial Boosts Stake in Integer Holdings
Magnetar Financial LLC acquired a new position in Integer Holdings Corporation, purchasing 18,295 shares valued at approximately $1.89 million in Q3 2026. This investment by the hedge fund suggests institutional confidence in Integer's growth potential as a medical device manufacturer and outsourcing partner. The move could indicate Magnetar's belief that Integer is currently undervalued.
Investor agreement sends two new financial experts to Integer board
Integer Holdings Corporation (NYSE: ITGR) has appointed James Flanagan and Aaron Kapito to its Board of Directors as independent directors, effective March 12, 2026. These appointments follow a cooperation agreement with Irenic Capital Management, LP and aim to bring significant financial, governance, and risk management expertise to the board. Two existing directors will not seek re-election at the upcoming annual stockholder meeting, consistent with Integer's board succession process.
Activist pact brings new directors to Integer (NYSE: ITGR)
Integer Holdings Corporation has entered a cooperation agreement with investment firm Irenic, resulting in the appointment of two independent directors, James F. Flanagan and Aaron Kapito, to its Board. This agreement, effective March 9, 2026, also involves two current directors not standing for re-election as part of a planned Board refresh and includes commitments such as voting, standstill, and non-disparagement provisions. The Board will temporarily expand to 13 members and then be capped at 11 members during the cooperation period.
Dimensional Fund Advisors LP Raises Stock Position in Integer Holdings Corporation $ITGR
Dimensional Fund Advisors LP increased its stake in Integer Holdings Corporation (NYSE:ITGR) by 4.9% in Q3, now owning 1,410,480 shares valued at $145.7 million. Other institutional investors also raised their positions, with institutional ownership of the stock reaching 99.29%. Integer recently surpassed Q4 earnings expectations with $1.76 EPS on revenue of $472.1 million and has a current average analyst rating of "Hold" with a price target of $102.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integer Holdings Corporation (ITGR) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential claims against Integer Holdings Corporation (ITGR) and its officers/directors for corporate wrongdoing. The firm encourages shareholders who purchased Integer securities before July 25, 2024, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to restore investor capital and ensure corporate accountability.
American Century Companies Inc. Sells 394,303 Shares of Integer Holdings Corporation $ITGR
American Century Companies Inc. significantly reduced its stake in Integer Holdings Corporation by 51.5% in the third quarter, selling 394,303 shares and retaining 370,749 shares valued at $38.31 million. This comes as Integer reported strong quarterly earnings, beating expectations with $1.76 EPS and $472.06 million in revenue, and provided optimistic FY2026 guidance. Analysts currently hold a mixed "Hold" consensus rating for Integer, with an average price target of $102.
Quantbot Technologies LP Sells 20,471 Shares of Integer Holdings Corporation $ITGR
Quantbot Technologies LP significantly reduced its stake in Integer Holdings Corporation (NYSE:ITGR) by selling 20,471 shares, cutting its holdings by 59.9%. Despite this, Integer recently surpassed quarterly earnings expectations and provided strong FY2026 guidance, though analyst ratings are mixed with a consensus "Hold." The stock, primarily owned by institutional investors, has a current market cap of $2.93 billion.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integer Holdings Corporation (ITGR) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Integer Holdings Corporation (ITGR) regarding potential corporate wrongdoing. The firm is encouraging shareholders who purchased Integer securities before July 25, 2024, and still hold them, to contact them to assist with the investigation. This class action aims to recover investor capital and ensure corporate accountability.
GW&K Investment Management LLC Has $42.99 Million Holdings in Integer Holdings Corporation $ITGR
GW&K Investment Management LLC reduced its stake in Integer Holdings Corporation (NYSE:ITGR) by 4.0% in Q3, now holding 416,077 shares valued at $42.99 million. Integer recently surpassed quarterly earnings estimates with $1.76 EPS and $472.06M revenue, projecting FY2026 EPS between $6.29 and $6.78. Despite high institutional ownership (99.29%), analysts have a consensus "Hold" rating with a target price of $102.
Integer Holdings at Raymond James Conference: Strategic Focus Amid Challenges
Integer Holdings presented at the 47th Annual Raymond James Institutional Investor Conference, detailing strong 2025 revenue growth and a strategic focus on long-term goals despite expected temporary headwinds in 2026. The company emphasized its robust pipeline, strategic acquisitions, and commitment to cardiovascular and cardiac rhythm management sectors, with confidence in returning to above-market growth by 2027. They clarified that 2026 challenges stem from three product ramps seeing slower adoption than anticipated, not competitive losses or insourcing.
Law Offices of Howard G. Smith Announces Investigation of Integer Holdings Corporation (ITGR) on Behalf of Investors
The Law Offices of Howard G. Smith announced an investigation into potential breaches of fiduciary duties by the board of directors of Integer Holdings Corporation (ITGR). This follows Integer's revised full-year 2025 sales guidance and anticipated slower growth for 2026, primarily due to underperforming new products and declining electrophysiology device sales. News of these revised forecasts on October 23, 2025, led to a significant 32.3% drop in Integer's stock price, injuring investors.
Law Offices of Howard G. Smith Announces Investigation of Integer Holdings Corporation (ITGR) on Behalf of Investors
The Law Offices of Howard G. Smith announced an investigation into Integer Holdings Corporation (ITGR) concerning potential breaches of fiduciary duties by its board of directors. This follows Integer's reduced full-year 2025 sales guidance and anticipated slower growth for 2026, which led to a significant drop in the company's stock price on October 23, 2025. The investigation focuses on whether the board's actions or inactions injured investors who held shares before July 2024.
Integer Holdings Shareholders Receive Notice
Integer Holdings Corp., a medical device manufacturer, announced that its long-term shareholders will receive notice of Molina Healthcare's acquisition of the company for $3.5 billion. The deal, expected to close in Q2 2026, will consolidate the medical device and healthcare industries. Molina Healthcare will acquire all outstanding shares for $85 per share in cash.
Integer Holdings Warns Activist Investor Campaigns Could Disrupt Strategy, Raise Costs, and Add Share-Price Volatility
Integer Holdings (ITGR) has identified a new risk in its latest disclosure, warning that activist investor campaigns could disrupt its long-term strategy and lead to increased costs and share-price volatility. Such campaigns might necessitate strategic shifts or governance changes, diverting management attention and straining stakeholder relationships. Despite this, Wall Street maintains a "Moderate Buy" consensus rating on ITGR stock.
Integer Holdings (NYSE: ITGR) details growth strategy, key customers and 2025 risks
Integer Holdings Corporation, a medical device CDMO, outlined its growth strategy, risks, and financial performance for 2025. The company focuses on Cardio & Vascular, Cardiac Rhythm Management, and Neuromodulation markets, with acquisitions in expertise areas like specialized coatings. Despite growth in sales, particularly in Cardio & Vascular, the company faces risks including customer concentration (Abbott, Boston Scientific, Medtronic accounted for 49% of 2025 revenue), supply chain disruptions, and intense competition.
Integer Holdings Corp. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics
Integer Holdings Corp. has reported robust financial performance for the quarter ending December 2025, with impressive metrics including a high interest coverage ratio, reduced raw material costs, and record operating, pre-tax, and net profits. Despite these strengths, the company faces challenges with receivables collection, indicated by a low debtors turnover ratio. Its stock performance has been mixed, outperforming the S&P 500 year-to-date but showing a significant decline over the past year.
